Page 4,504«..1020..4,5034,5044,5054,506..4,5104,520..»

New Parkinsons Treatment at Emory University Hospital

Posted: Published on April 4th, 2014

ATLANTA (CBS46) - April is Parkinson's Awareness Month, and now there is a new procedure being done right here in Atlanta to help those with the disease. Instead of being awake for hours while doctors operate on your brain, patients can now be put under anesthesia. In years past, patients would have to be awake for ten hours or more as doctors use old MRI images to navigate the brain. Therefore it's no surprise that Gwyn Hazelwood, who has been battling Parkinson's for more than twenty years, did not want to go under the knife. "You think of surgery on your head and that's extreme for most of us," said Hazelwood. For the past two decades, Hazelwood's condition progressively worsened. Her legs and arms shook uncontrollably. Her daughter told us she couldn't event lift her grandchildren. "She was practically crawling through the hallways. It was like watching a baby," said Erica Brown, Hazelwood's daughter. Enter a new piece of technology called ClearPoint. It allows doctors to use 3D, real-time images of the brain throughout the procedure. That's not all. Patients get to be asleep the entire time. Dr. Robert Gross, brain surgeon at Emory University Hospital, told CBS46 that the … Continue reading

Posted in Parkinson's Treatment | Comments Off on New Parkinsons Treatment at Emory University Hospital

Pediapharm, Inc. and Merz Pharma Canada, Ltd. Enter Into a Distribution and Supply Agreement for CUVPOSA(TM …

Posted: Published on April 4th, 2014

Pediapharm Inc. ("Pediapharm") (TSX VENTURE:PDP) and Merz Pharma Canada, Ltd. ("Merz") announce they have entered into an agreement regarding the Canadian rights to CUVPOSA (glycopyrrolate) oral solution intended for pediatric chronic severe drooling (sialorrhea) associated with neurologic conditions such as cerebral palsy. Pediapharm was granted exclusive commercial rights for the product in Canada. "Merz is pleased to be expanding patient and physician access to Cuvposa (glycopyrrolate) oral solution through this new agreement with Pediapharm," said Bob Bennett, President and General Manager of Merz Pharma Canada. "We are dedicated to improving the quality of life for patients suffering from movement and neurological disorders such as cerebral palsy, and we look forward to collaborating with Pediapharm in order to achieve this goal." Cerebral palsy (CP) is a lifelong condition that encompasses a group of non-progressive, neurological disorders affecting body movement and muscle coordination. "Based on our discussions with experts in the field, chronic severe drooling is a poorly managed condition in up to 30% of children with CP. Because the treatment options available in Canada are limited, this may lead to various health issues and a decreased quality of life in that patient population", said Benot Hbert, Pediapharm's Vice President of Business … Continue reading

Posted in Cerebral Palsy Treatment | Comments Off on Pediapharm, Inc. and Merz Pharma Canada, Ltd. Enter Into a Distribution and Supply Agreement for CUVPOSA(TM …

Former player sues NCAA seeking brain-injury screening

Posted: Published on April 4th, 2014

While the NFL has reached a preliminary settlement on brain injury claims from former players, cases against the NCAA are still piling up. A former New Jersey college football player from Long Island has filed a new class action suit in Brooklyn federal court against the collegiate body to force them to provide diagnostic testing. Joel Jackson, who starred at Elmont Memorial High School before playing at Division III Morristown State, has yet to show any signs of damage from his playing days but wants to ensure that he will be able to detect any problems in the future, the suit states. The NCAA is in some fashion legally responsible for the present and future medical surveillance and diagnostic treatment to protect Plaintiff Joel Jackson and the Plaintiff class, the suit states. The NCAA is facing down a mountain of brain injury lawsuits from former players. But while most of them are related to former student-athletes who have shown tangible signs of damage, Jackson wants the body to foot the bill for lifelong diagnostic tests and monitoring. Now a health industry professional, Jackson, 25, claims in the suit that the NCAA has failed to provide proper measures to deal with … Continue reading

Posted in Brain Injury Treatment | Comments Off on Former player sues NCAA seeking brain-injury screening

Rare, But Serious, Side Effect Reported With One MS Drug

Posted: Published on April 4th, 2014

By Serena Gordon HealthDay Reporter WEDNESDAY, April 2, 2014 (HealthDay News) -- A handful of people taking a medication called Rebif to treat multiple sclerosis have developed a serious condition that causes blood clots to form in small blood vessels throughout the body. In a letter in the March 27 issue of the New England Journal of Medicine, Scottish researchers reported that they found an unexpectedly high number of cases of "thrombotic microangiopathy" in people taking Rebif who suddenly developed severe high blood pressure. The condition is a combination of the clotting disorders hemolytic-uremic syndrome and thrombotic thrombocytopenic purpura (HUS/TTP). The two disorders often occur together. In HUS, the red blood cells are destroyed, and the debris from that destruction clumps together and clots. Those numerous blood clots cause TTP, which occurs when small blood vessels throughout the body become blocked with blood clots, according to the U.S. National Library of Medicine. The clotting condition is a recognized complication of using Rebif, which is one of the brand names for the drug interferon beta 1-alpha, said study senior author Siddharthan Chandran, a professor of neurology at the University of Edinburgh. In fact, British regulatory authorities issued a drug-safety update last … Continue reading

Posted in MS Treatment | Comments Off on Rare, But Serious, Side Effect Reported With One MS Drug

Networking, Professionalism, and the Internet

Posted: Published on April 4th, 2014

The digital revolution has transformed society and forever altered the practice of psychiatry. Technology permeates our daily lives and poses new social and professional challenges (Table 1).1 The speed, range, and permanence of digital communication magnify both its efficiency and the effects of breeches in professionalism. Few standards exist regarding the use of technology in medicine, and those that do exist can become quickly outdated as technology advances and patient expectations and standard-of-care practices continue to change. In psychiatry, professional challenges are heightened by the importance of the psychiatrist-patient relationship. Because of its intimacy, the sensitivity of clinical content, and stigma about mental illness, the psychiatrist-patient relationship must be one of safety and trust. However, psychiatric patients deserve the same access to medical information and up-to-date clinical care practices that all medical patients merit and that technology may enhance. How can psychiatrists integrate technology professionally into clinical practice? This article addresses key concerns that can arise with the use of technology. It then looks at promising technological opportunities that can be integrated into psychiatric practice while respecting professional boundaries. Finally, recommendations for use of technology in psychiatric practice are discussed. Clinical care and liability While technology offers opportunities for improving … Continue reading

Comments Off on Networking, Professionalism, and the Internet

Genetic determinants of pulmonary fibrosis: evolving concepts : The Lancet Respiratory Medicine

Posted: Published on April 4th, 2014

Genome-wide association studies (GWAS) represent an unbiased and hypothesis-free method based on the data produced by the human HapMap Project and the fact that genetic variance at one locus can predict, with high probability, genetic variance at adjacent loci.49 As such, the human genome can be surveyed for common variants (those present in more than 5% of the population) by genotyping about 500000 accurately chosen markers, so-called tag single nucleotide polymorphisms.50 GWAS have led to the identification of thousands of loci that affect susceptibility to complex disorders, broadening understanding of the pathogenesis of many diseases.51 However, inherent drawbacks of these studies are an inability to identify sequence variants (the studies identify loci) and rare alleles, detection of non-coding variants of unknown effect, reproducibility, and, in most cases, identification of susceptibility variants that confer only a small risk of disease. In a genome-wide scan (followed by hierarchical fine mapping in a larger dataset) of six multiplex families with familial idiopathic pulmonary fibrosis from southeastern Finland, Hodgson and colleagues52 identified a shared haplotype on chromosome 4q31 that was more common in affected individuals than in healthy controls. This haplotype harboured ELMOD2, a gene expressed in alveolar macrophages and alveolar epithelium. Although ELMOD2 … Continue reading

Comments Off on Genetic determinants of pulmonary fibrosis: evolving concepts : The Lancet Respiratory Medicine

Genetic science is transforming health care and introducing ethical dilemmas

Posted: Published on April 4th, 2014

Inheritance Dr. Sharon Moalem (Grand Central Publishing) In Town: The author will appear at the Ottawa Writers Festival on April 24 at 6:30 p.m., Knox Presbyterian Church, 120 Lisgar St. When Californian Craig Venter sequenced his own genome in the year 2000, he wittingly started a great transformation that is now taking hold in the delivery of health care. But that change is unfolding in a global society that is not ready. Thats the warning delivered by Dr. Sharon Moalem, a medical doctor, geneticist, businessman, inventor and author of the book Inheritance: How Our Genes Change Our Lives and Our Lives Change Our Genes. Moalem will appear at the Ottawa Writers Festival and what he has to say is kind of mind-blowing. First of all, because we now have the ability to sequence everyones genome and see all the markers that a person has, we can see clearly the consequences of personal choices. For example, one person may not be able to metabolize caffeine and probably shouldnt drink a lot of coffee, while another has no problem with sugar and can drink all the soft drinks she wants. For Moalem, who has focused on rare diseases over his career, sequencing … Continue reading

Comments Off on Genetic science is transforming health care and introducing ethical dilemmas

Introduction to Stem Cell Therapy – Video

Posted: Published on April 3rd, 2014

Introduction to Stem Cell Therapy Dr. Michael Belich of Integrative Medical Clinics talks about Stem Cell Therapy basics. For more detailed information go to http://www.integrativemc.com.au. By: Integrative Medical Clinics … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on Introduction to Stem Cell Therapy – Video

New York Podiatrist Dr. Jeffrey Adler to Be Interviewed April 5 on NewsTalkRadio 77 WABC About the Use of Stem Cell …

Posted: Published on April 3rd, 2014

New York, New York (PRWEB) April 03, 2014 Dr. Jeffrey Adler, New York podiatrist and Owner/Medical Director of Adler Footcare New York, will be interviewed by radio personality Laura Smith and taking live calls on New York talk show 77 WABC about the use of stem cells to treat chronic foot pain. Adler Footcare New York uses live birth stem cells to help treat patients with chronic foot problems such as: Plantar fasciitis, Osteoarthritis, Achilles tendonitis and torn soft tissue. The stem cell treatment is proving to be much more effective than traditional treatments like physical therapy or orthotic therapy. Stem cells have the ability to replicate themselves or change into the cell type that is needed to repair damaged tissue. The therapy works by directly introducing live stem cells into the affected area causing pain. Its approved by the FDA and consistently reviewed by medical professionals to remove the potential of any communicable diseases. Dr. Adler often travels to other states to share his knowledge with other doctors in his profession. His latest research on stem cell therapy has gained much interest among his peers in the medical industry. When compared to traditional treatments, stem therapy is proving to … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on New York Podiatrist Dr. Jeffrey Adler to Be Interviewed April 5 on NewsTalkRadio 77 WABC About the Use of Stem Cell …

Using stem cells in breast reconstruction – Video

Posted: Published on April 3rd, 2014

Using stem cells in breast reconstruction The advantages linked to the use are mainly due to the effects of post-mastectomy radiotherapy. Mesenchymal stem cells are able to both restore and reduce po... By: Xellbiogene … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on Using stem cells in breast reconstruction – Video

Page 4,504«..1020..4,5034,5044,5054,506..4,5104,520..»